Drug Shortage Report for NOVO-PROFEN
Report ID | 42644 |
Drug Identification Number | 00629340 |
Brand name | NOVO-PROFEN |
Common or Proper name | PROFEN |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | IBUPROFEN |
Strength(s) | 400MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 50 |
ATC code | M01AE |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-03-07 |
Estimated end date | 2018-03-30 |
Actual end date | 2018-04-30 |
Shortage status | Resolved |
Updated date | 2018-05-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-03-13 | English | Compare |
v2 | 2018-03-13 | French | Compare |
v3 | 2018-05-30 | English | Compare |
v4 | 2018-05-30 | French | Compare |
Showing 1 to 4 of 4